1. Deformation-based morphometry applied to FDG PET data reveals hippocampal atrophy in Alzheimer's disease.
- Author
-
Frings L, Blazhenets G, Brumberg J, Rau A, Urbach H, and Meyer PT
- Subjects
- Humans, Male, Aged, Female, Retrospective Studies, Positron Emission Tomography Computed Tomography methods, Aged, 80 and over, Middle Aged, ROC Curve, Alzheimer Disease diagnostic imaging, Alzheimer Disease pathology, Alzheimer Disease metabolism, Hippocampus diagnostic imaging, Hippocampus pathology, Hippocampus metabolism, Fluorodeoxyglucose F18, Atrophy pathology, Positron-Emission Tomography methods, Magnetic Resonance Imaging methods
- Abstract
Cerebral atrophy is a key finding in patients with dementia and usually determined on MRI. We tested whether cerebral atrophy can be imaged with FDG PET by applying deformation-based morphometry (DBM). We retrospectively identified 26 patients with a biomarker-supported clinical diagnosis of Alzheimer's disease (AD) who had received FDG PET on a fully-digital PET/CT system and structural MRI and compared them to 13 healthy elderly controls (HEC). We performed DBM with FDG PET data (FDG-DBM). As a reference standard for determining atrophy we used voxel-based morphometry of MRI data (MRI-VBM). For conventional analysis of hypometabolism, scaled FDG PET scans (reference: brain parenchyma) were compared between groups. Receiver operating characteristic (ROC) analyses were performed. ROI read-outs were tested for associations with cognitive test performance. FDG-DBM showed abnormalities in AD mainly in the bilateral hippocampi. Similarly, MRI-VBM showed hippocampal atrophy. By contrast, conventional FDG PET analysis revealed reduced bilateral temporo-parietal FDG uptake (all p < 0.05, FWE-corrected). FDG-DBM measures of the hippocampus significantly separated AD from HEC with an AUC of 0.81; MRI-VBM achieved an AUC of 0.87; the difference between the two ROC curves was not significant (p = 0.40). Whereas FDG uptake of the hippocampus did not separate AD from HEC, FDG uptake of the Landau Meta-ROI achieved an AUC of 0.88. Verbal memory was significantly associated with FDG-DBM measures of the hippocampus (p = 0.009), but not of the Landau Meta-ROI (p > 0.1). The opposite held true for conventional FDG uptake (p > 0.1 and p = 0.001, respectively). Hippocampal atrophy in AD can be detected by applying DBM to clinical, fully-digital FDG PET. It correlates with cognitive performance and might constitute a biomarker of neurodegeneration that is complementary to conventional FDG PET analysis of regional hypometabolism., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF